These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18236042)

  • 1. A33 antigen displays persistent surface expression.
    Ackerman ME; Chalouni C; Schmidt MM; Raman VV; Ritter G; Old LJ; Mellman I; Wittrup KD
    Cancer Immunol Immunother; 2008 Jul; 57(7):1017-27. PubMed ID: 18236042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium.
    Ritter G; Cohen LS; Nice EC; Catimel B; Burgess AW; Moritz RL; Ji H; Heath JK; White SJ; Welt S; Old LJ; Simpson RJ
    Biochem Biophys Res Commun; 1997 Jul; 236(3):682-6. PubMed ID: 9245713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
    Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
    Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer.
    Sakamoto J; Kojima H; Kato J; Hamashima H; Suzuki H
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S27-32. PubMed ID: 10950144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
    Ritter G; Cohen LS; Williams C; Richards EC; Old LJ; Welt S
    Cancer Res; 2001 Sep; 61(18):6851-9. PubMed ID: 11559561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium.
    Moritz RL; Ritter G; Catimel B; Cohen LS; Welt S; Old LJ; Burgess AW; Nice EC; Simpson RJ
    J Chromatogr A; 1998 Mar; 798(1-2):91-101. PubMed ID: 9542130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of 211 At-labeled antibody A33--a potential therapeutic agent against metastatic colorectal carcinoma.
    Almqvist Y; Orlova A; Sjöström A; Jensen HJ; Lundqvist H; Sundin A; Tolmachev V
    Cancer Biother Radiopharm; 2005 Oct; 20(5):514-23. PubMed ID: 16248767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A33 antigen-deficient mice have defective colonic mucosal repair.
    Pereira-Fantini PM; Judd LM; Kalantzis A; Peterson A; Ernst M; Heath JK; Giraud AS
    Inflamm Bowel Dis; 2010 Apr; 16(4):604-12. PubMed ID: 19856415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Divgi CR; Kemeny N; Finn RD; Scott AM; Graham M; Germain JS; Richards EC; Larson SM; Oettgen HF
    J Clin Oncol; 1994 Aug; 12(8):1561-71. PubMed ID: 8040668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor.
    Mao Z; Song S; Zhu Y; Yi X; Zhang H; Shang Y; Tong T
    Oncogene; 2003 Jul; 22(28):4434-43. PubMed ID: 12853980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
    Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
    Scanlan MJ; Ritter G; Yin BW; Williams C; Cohen LS; Coplan KA; Fortunato SR; Frosina D; Lee SY; Murray AE; Chua R; Filonenko VV; Sato E; Old LJ; Jungbluth AA
    Cancer Immun; 2006 Jan; 6():2. PubMed ID: 16405301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.
    Ilantzis C; Jothy S; Alpert LC; Draber P; Stanners CP
    Lab Invest; 1997 May; 76(5):703-16. PubMed ID: 9166289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids.
    Ackerman ME; Pawlowski D; Wittrup KD
    Mol Cancer Ther; 2008 Jul; 7(7):2233-40. PubMed ID: 18645032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic analysis of the novel antigen for the gastrointestinal-specific monoclonal antibody, A33.
    Ji H; Moritz RL; Reid GE; Ritter G; Catimel B; Nice E; Heath JK; White SJ; Welt S; Old LJ; Burgess AW; Simpson RJ
    Electrophoresis; 1997; 18(3-4):614-21. PubMed ID: 9150949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Targeting of TAG72
    Murad JP; Kozlowska AK; Lee HJ; Ramamurthy M; Chang WC; Yazaki P; Colcher D; Shively J; Cristea M; Forman SJ; Priceman SJ
    Front Immunol; 2018; 9():2268. PubMed ID: 30510550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
    Deckert PM; Bornmann WG; Ritter G; Williams C; Franke J; Keilholz U; Thiel E; Old LJ; Bertino JR; Welt S
    Int J Oncol; 2004 May; 24(5):1289-95. PubMed ID: 15067353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Scott AM; Divgi CR; Kemeny NE; Finn RD; Daghighian F; Germain JS; Richards EC; Larson SM; Old LJ
    J Clin Oncol; 1996 Jun; 14(6):1787-97. PubMed ID: 8656247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis.
    Murer P; Plüss L; Neri D
    MAbs; 2020; 12(1):1714371. PubMed ID: 31928310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft.
    Barendswaard EC; Humm JL; O'Donoghue JA; Sgouros G; Finn RD; Scott AM; Larson SM; Welt S
    J Nucl Med; 2001 Aug; 42(8):1251-6. PubMed ID: 11483688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.